Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Mar 24, 2022 11:05am
127 Views
Post# 34541382

RE:I suspect we have proof of concept already

RE:I suspect we have proof of concept alreadyYou have to be correct SPCE01.  I'm not a scientist; I'm in the finance space.  I can see all the related business moves and it just makes sense that they have something meaningful coming.  I sent Dubuc an email two days ago asking what the leadership team was going to do different, now that we are sitting at 52 week lows.  Specifically, what is he as head of IR going to do?  I told him the stock price is a reflection of the leadership team, there lack of communication, and the fact that they've allowed other professionals, investors, speculators to create the narrative for them.  They should be controlling the narrative, and they've simply passed on that fiduciary responsibility.  They can post all the scientific charts they want.  Us non-science guys won't understand how to interpret it and with such low liquidity and quite a few of us retail investors owning 50K+ shares, we can move the share price in a meaningful direction pretty easily.  They need to reassure the markets in a different way.  They are way to close to an outcome to let the stock continue to slip like this.  I'm still voting against every single one of them off the board when the time comes even if the stock pops by then.  This has been a disaster for all of us and the risk spread is spiraling out of control, creating what is likely a false narrative, when it should be bridging a significant gap leading into the upcoming results.  THTX is creative with science.  Get creative with engaging the markets.  
<< Previous
Bullboard Posts
Next >>